
To study the impact of spironolactone on key echocardiographic parameters in HFpEF. A total of 984 patients were included in this analysis: HOMAGE=452 (45.9%), ALDO‐DHF=398 (40.4%), and TOPCAT=134 (13.6%). Spironolactone improved the cardiac structure and function of patients with HFpEF.
Like
Save
Share